MENU
+Compare
CLSD
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$4.04
Change
+$0.31 (+8.31%)
Capitalization
21.15M

CLSD Clearside Biomedical Inc Forecast, Technical & Fundamental Analysis

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company... Show more

CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLSD with price predictions
Sep 25, 2025

CLSD's RSI Indicator ascending out of oversold territory

The RSI Oscillator for CLSD moved out of oversold territory on September 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for CLSD just turned positive on September 22, 2025. Looking at past instances where CLSD's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLSD advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLSD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLSD as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLSD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CLSD entered a downward trend on September 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (4.936) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CLSD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLSD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLSD is expected to report earnings to fall 32.90% to -6 cents per share on November 18

Clearside Biomedical Inc CLSD Stock Earnings Reports
Q3'25
Est.
$-0.07
Q2'25
Est.
$-0.10
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.10
Q3'24
Beat
by $0.02
The last earnings report on August 18 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 99.12K shares outstanding, the current market capitalization sits at 21.15M.
A.I. Advisor
published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELPW0.340.01
+3.43%
Elong Power Holding Limited
WEC112.851.61
+1.45%
WEC Energy Group
KOD15.800.12
+0.77%
Kodiak Sciences
GNFT3.550.02
+0.45%
Genfit SA
VIST36.17-0.86
-2.32%
Vista Energy SAB de CV

CLSD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+7.24%
ABVX - CLSD
50%
Loosely correlated
+0.98%
IMNN - CLSD
30%
Poorly correlated
+0.39%
ANEB - CLSD
29%
Poorly correlated
-1.64%
BOLT - CLSD
29%
Poorly correlated
-2.00%
ACLX - CLSD
28%
Poorly correlated
+1.64%
More